IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $15,535,000 | +88.8% | 191,384 | +25.8% | 0.02% | +58.3% |
| Q4 2018 | $8,227,000 | -48.7% | 152,186 | -51.1% | 0.01% | +20.0% |
| Q3 2018 | $16,050,000 | +180.3% | 311,182 | +126.5% | 0.01% | +42.9% |
| Q2 2018 | $5,726,000 | -5.2% | 137,413 | +0.3% | 0.01% | -12.5% |
| Q1 2018 | $6,042,000 | -10.4% | 137,067 | +2.3% | 0.01% | -11.1% |
| Q4 2017 | $6,741,000 | +0.7% | 134,007 | +1.4% | 0.01% | 0.0% |
| Q3 2017 | $6,697,000 | -12.6% | 132,094 | -12.3% | 0.01% | -18.2% |
| Q2 2017 | $7,664,000 | +44.8% | 150,656 | +14.4% | 0.01% | +37.5% |
| Q1 2017 | $5,293,000 | -10.6% | 131,656 | +6.3% | 0.01% | -11.1% |
| Q4 2016 | $5,922,000 | +49.8% | 123,810 | +14.7% | 0.01% | +28.6% |
| Q3 2016 | $3,954,000 | +40.1% | 107,906 | -11.0% | 0.01% | +40.0% |
| Q2 2016 | $2,823,000 | -38.7% | 121,204 | +6.6% | 0.01% | -37.5% |
| Q1 2016 | $4,606,000 | -32.8% | 113,727 | +2.8% | 0.01% | -38.5% |
| Q4 2015 | $6,851,000 | – | 110,630 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |